Astrana Health, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Astrana Health, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Dec 31, 2018 | $519.91M | Mar 18, 2019 |
| FY2018 | Dec 31, 2017 | $356.36M | Mar 18, 2019 |
| FY2017 | Mar 31, 2017 | $57.43M | Jun 29, 2017 |
| FY2017 | Mar 31, 2016 | $44.05M | Jun 29, 2017 |
| FY2016 | Mar 31, 2015 | $32.99M | Jun 29, 2016 |
| FY2015 | Mar 31, 2014 | $2.34M | Jul 14, 2015 |
| FY2013 | Jan 31, 2014 | $2.84M | May 8, 2014 |
| FY2013 | Oct 31, 2013 | $2.61M | May 8, 2014 |
| FY2013 | Jul 31, 2013 | $2.59M | May 8, 2014 |
| FY2013 | Apr 30, 2013 | $2.45M | May 8, 2014 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.18B | Mar 12, 2026 |
| FY2025 | Dec 31, 2024 | $2.03B | Mar 12, 2026 |
| FY2025 | Dec 31, 2023 | $1.39B | Mar 12, 2026 |
| FY2022 | Dec 31, 2022 | $294.21M | Aug 9, 2023 |
| FY2022 | Sep 30, 2022 | $317.00M | Aug 9, 2023 |
| FY2022 | Jun 30, 2022 | $269.70M | Aug 9, 2023 |
| FY2022 | Mar 31, 2022 | $263.26M | Aug 9, 2023 |
| FY2022 | Dec 31, 2021 | $195.10M | Aug 9, 2023 |
| FY2022 | Sep 30, 2021 | $227.12M | Aug 9, 2023 |
| FY2022 | Jun 30, 2021 | $175.64M | Aug 9, 2023 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $357.75M | Apr 2, 2018 |
| FY2017 | Dec 31, 2016 | $305.93M | Apr 2, 2018 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2013 | Jan 31, 2014 | $1.41M | May 8, 2014 |
| FY2012 | Jan 31, 2013 | $1.46M | May 1, 2013 |
| FY2011 | Jan 31, 2012 | $978.4K | May 15, 2012 |
| FY2011 | Jan 31, 2011 | $581.9K | May 15, 2012 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $22.49M | Mar 12, 2026 |
| FY2025 | Dec 31, 2024 | $43.15M | Mar 12, 2026 |
| FY2025 | Dec 31, 2023 | $60.72M | Mar 12, 2026 |
| FY2022 | Dec 31, 2022 | ($3.73M) | Aug 9, 2023 |
| FY2022 | Sep 30, 2022 | $23.19M | Aug 9, 2023 |
| FY2022 | Jun 30, 2022 | $11.95M | Aug 9, 2023 |
| FY2022 | Mar 31, 2022 | $13.76M | Aug 9, 2023 |
| FY2022 | Dec 31, 2021 | $12.28M | Aug 9, 2023 |
| FY2022 | Sep 30, 2021 | $34.40M | Aug 9, 2023 |
| FY2022 | Jun 30, 2021 | $10.09M | Aug 9, 2023 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $78.53M | Mar 12, 2026 |
| FY2025 | Dec 31, 2024 | $89.35M | Mar 12, 2026 |
| FY2025 | Dec 31, 2023 | $84.61M | Mar 12, 2026 |
| FY2022 | Dec 31, 2022 | $12.58M | Aug 9, 2023 |
| FY2022 | Sep 30, 2022 | $50.09M | Aug 9, 2023 |
| FY2022 | Jun 30, 2022 | $15.38M | Aug 9, 2023 |
| FY2022 | Mar 31, 2022 | $26.21M | Aug 9, 2023 |
| FY2022 | Dec 31, 2021 | $2.25M | Aug 9, 2023 |
| FY2022 | Sep 30, 2021 | $53.16M | Aug 9, 2023 |
| FY2022 | Jun 30, 2021 | $20.99M | Aug 9, 2023 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $114.60M | Mar 12, 2026 |
| FY2025 | Dec 31, 2024 | $52.20M | Mar 12, 2026 |
| FY2025 | Dec 31, 2023 | $68.23M | Mar 12, 2026 |
| FY2024 | Dec 31, 2022 | $82.13M | Mar 14, 2025 |
| FY2023 | Dec 31, 2021 | $70.34M | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $46.16M | Aug 9, 2023 |
| FY2021 | Dec 31, 2019 | $13.67M | Feb 28, 2022 |
| FY2020 | Dec 31, 2018 | $25.50M | Mar 15, 2021 |
| FY2019 | Dec 31, 2017 | $51.83M | Mar 16, 2020 |
| FY2017 | Dec 31, 2016 | $21.91M | Apr 2, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $10.11M | Mar 12, 2026 |
| FY2025 | Dec 31, 2024 | $8.03M | Mar 12, 2026 |
| FY2025 | Dec 31, 2023 | $28.53M | Mar 12, 2026 |
| FY2024 | Dec 31, 2022 | $22.94M | Mar 14, 2025 |
| FY2023 | Dec 31, 2021 | $19.22M | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $1.16M | Aug 9, 2023 |
| FY2021 | Dec 31, 2019 | $1.04M | Feb 28, 2022 |
| FY2020 | Dec 31, 2018 | $1.17M | Mar 15, 2021 |
| FY2019 | Dec 31, 2017 | $2.08M | Mar 16, 2020 |
| FY2017 | Mar 31, 2017 | $297.6K | Jun 29, 2017 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.22B | Mar 12, 2026 |
| FY2025 | Dec 31, 2024 | $1.35B | Mar 12, 2026 |
| FY2024 | Dec 31, 2023 | $933.36M | Mar 14, 2025 |
| FY2023 | Dec 31, 2022 | $966.21M | Feb 29, 2024 |
| FY2022 | Sep 30, 2022 | $954.90M | Aug 9, 2023 |
| FY2022 | Jun 30, 2022 | $967.43M | Aug 9, 2023 |
| FY2022 | Mar 31, 2022 | $922.66M | Aug 9, 2023 |
| FY2022 | Dec 31, 2021 | $867.36M | Aug 9, 2023 |
| FY2022 | Sep 30, 2021 | $871.15M | Aug 9, 2023 |
| FY2022 | Jun 30, 2021 | $895.72M | Aug 9, 2023 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.66B | Mar 12, 2026 |
| FY2025 | Dec 31, 2024 | $840.73M | Mar 12, 2026 |
| FY2024 | Dec 31, 2023 | $522.59M | Mar 14, 2025 |
| FY2023 | Dec 31, 2022 | $407.67M | Feb 29, 2024 |
| FY2022 | Sep 30, 2022 | $410.36M | Aug 9, 2023 |
| FY2022 | Jun 30, 2022 | $446.89M | Aug 9, 2023 |
| FY2022 | Mar 31, 2022 | $396.97M | Aug 9, 2023 |
| FY2022 | Dec 31, 2021 | $356.72M | Aug 9, 2023 |
| FY2022 | Sep 30, 2021 | $346.13M | Aug 9, 2023 |
| FY2022 | Jun 30, 2021 | $356.23M | Aug 9, 2023 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $779.29M | Mar 12, 2026 |
| FY2025 | Dec 31, 2024 | $712.72M | Mar 12, 2026 |
| FY2024 | Dec 31, 2023 | $614.22M | Mar 14, 2025 |
| FY2023 | Dec 31, 2022 | $542.56M | Feb 29, 2024 |
| FY2022 | Sep 30, 2022 | $504.37M | Aug 9, 2023 |
| FY2022 | Jun 30, 2022 | $479.51M | Aug 9, 2023 |
| FY2022 | Mar 31, 2022 | $472.64M | Aug 9, 2023 |
| FY2022 | Dec 31, 2021 | $448.17M | Aug 9, 2023 |
| FY2022 | Sep 30, 2021 | $435.24M | Aug 9, 2023 |
| FY2022 | Jun 30, 2021 | $399.37M | Aug 9, 2023 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $865.31M | Mar 12, 2026 |
| FY2025 | Dec 31, 2024 | $419.25M | Mar 12, 2026 |
| FY2025 | Dec 31, 2023 | $278.83M | Mar 12, 2026 |
| FY2024 | Dec 31, 2022 | $269.05M | Mar 14, 2025 |
| FY2022 | Sep 30, 2022 | $250.86M | Aug 9, 2023 |
| FY2022 | Jun 30, 2022 | $246.69M | Aug 9, 2023 |
| FY2022 | Mar 31, 2022 | $245.76M | Aug 9, 2023 |
| FY2023 | Dec 31, 2021 | $246.42M | Feb 29, 2024 |
| FY2022 | Sep 30, 2021 | $236.73M | Aug 9, 2023 |
| FY2022 | Jun 30, 2021 | $232.43M | Aug 9, 2023 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $308.38M | Mar 12, 2026 |
| FY2025 | Dec 31, 2024 | $286.28M | Mar 12, 2026 |
| FY2024 | Dec 31, 2023 | $243.13M | Mar 14, 2025 |
| FY2023 | Dec 31, 2022 | $182.42M | Feb 29, 2024 |
| FY2022 | Sep 30, 2022 | $186.15M | Aug 9, 2023 |
| FY2022 | Jun 30, 2022 | $162.96M | Aug 9, 2023 |
| FY2022 | Mar 31, 2022 | $151.01M | Aug 9, 2023 |
| FY2022 | Dec 31, 2021 | $137.25M | Aug 9, 2023 |
| FY2022 | Sep 30, 2021 | $124.78M | Aug 9, 2023 |
| FY2022 | Jun 30, 2021 | $90.37M | Aug 9, 2023 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $429.47M | Mar 12, 2026 |
| FY2025 | Dec 31, 2024 | $288.46M | Mar 12, 2026 |
| FY2025 | Dec 31, 2023 | $293.81M | Mar 12, 2026 |
| FY2024 | Dec 31, 2022 | $288.03M | Mar 14, 2025 |
| FY2023 | Dec 31, 2021 | $233.10M | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $193.47M | Aug 9, 2023 |
| FY2021 | Dec 31, 2019 | $103.19M | Feb 28, 2022 |
| FY2020 | Dec 31, 2018 | $106.89M | Mar 15, 2021 |
| FY2019 | Dec 31, 2017 | $99.75M | Mar 16, 2020 |
| FY2017 | Mar 31, 2017 | $8.66M | Jun 29, 2017 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2019 | Dec 31, 2019 | $232.17M | Mar 16, 2020 |
| FY2015 | Mar 31, 2015 | $10.72M | Jul 14, 2015 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 12, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 12, 2026 |
| FY2025 | Dec 31, 2023 | 1 | Mar 12, 2026 |
| FY2022 | Dec 31, 2022 | 0 | Aug 9, 2023 |
| FY2022 | Sep 30, 2022 | 0 | Aug 9, 2023 |
| FY2022 | Jun 30, 2022 | 0 | Aug 9, 2023 |
| FY2022 | Mar 31, 2022 | 0 | Aug 9, 2023 |
| FY2022 | Dec 31, 2021 | 0 | Aug 9, 2023 |
| FY2022 | Sep 30, 2021 | 0 | Aug 9, 2023 |
| FY2022 | Jun 30, 2021 | 0 | Aug 9, 2023 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 12, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 12, 2026 |
| FY2025 | Dec 31, 2023 | 1 | Mar 12, 2026 |
| FY2022 | Dec 31, 2022 | 0 | Aug 9, 2023 |
| FY2022 | Sep 30, 2022 | 0 | Aug 9, 2023 |
| FY2022 | Jun 30, 2022 | 0 | Aug 9, 2023 |
| FY2022 | Mar 31, 2022 | 0 | Aug 9, 2023 |
| FY2022 | Dec 31, 2021 | 0 | Aug 9, 2023 |
| FY2022 | Sep 30, 2021 | 0 | Aug 9, 2023 |
| FY2022 | Jun 30, 2021 | 0 | Aug 9, 2023 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 48.89M | Mar 12, 2026 |
| FY2025 | Dec 31, 2024 | 47.93M | Mar 12, 2026 |
| FY2025 | Nov 15, 2023 | 500,000 | Mar 12, 2026 |
| FY2019 | Dec 31, 2019 | 35.91M | Mar 16, 2020 |
| FY2019 | Dec 31, 2018 | 34.58M | Mar 16, 2020 |
| FY2018 | Dec 31, 2017 | 32.30M | Mar 18, 2019 |
| FY2017 | Mar 31, 2017 | 6.03M | Jun 29, 2017 |
| FY2017 | Dec 31, 2016 | 25.07M | Apr 2, 2018 |
| FY2017 | Mar 31, 2016 | 5.88M | Jun 29, 2017 |
| FY2016 | Mar 31, 2015 | 4.86M | Jun 29, 2016 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $7.89M | Mar 12, 2026 |
| FY2025 | Dec 31, 2024 | $4.04M | Mar 12, 2026 |
| FY2025 | Dec 31, 2023 | $62.07M | Mar 12, 2026 |
| FY2024 | Dec 31, 2022 | $14.03M | Mar 14, 2025 |
| FY2023 | Dec 31, 2021 | $31.09M | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $51.32M | Aug 9, 2023 |
| FY2021 | Dec 31, 2019 | $61.72M | Feb 28, 2022 |
| FY2020 | Dec 31, 2018 | $17.76M | Mar 15, 2021 |